Supply chain transparency and the availability of essential medicines

被引：19

作者：

Ardal, Christine ^{[1
]}

Baraldi, Enrico ^{[2
]}

Beyer, Peter ^{[3
]}

Lacotte, Yohann ^{[4
]}

Larsson, D. G. Joakim ^{[5
]}

Ploy, Marie-Cecile ^{[4
]}

Rottingen, John -Arne ^{[6
]}

Smith, Ingrid ^{[7
]}

机构：

[1] Norwegian Inst Publ Hlth, Antimicrobial Resistance Ctr, Postboks 222 Skoyen, N-0213 Oslo, Norway

[2] Uppsala Univ, Dept Civil & Ind Engn, Uppsala, Sweden

[3] WHO, Dept Global Coordinat & Partnership, Geneva, Switzerland

[4] Univ Limoges, RESINFIT, Limoges, France

[5] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden

[6] Res Council Norway, Lysaker, Norway

[7] Haukeland Hosp, Dept Res & Dev, Bergen, Norway

来源：

BULLETIN OF THE WORLD HEALTH ORGANIZATION | 2021年 / 99卷 / 04期

关键词：

D O I：

10.2471/BLT.20.267724

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：319 / 320

页数：2

共 11 条

[1]

[Anonymous], 2020, MED SHORT EU CAUS SO

[2]

[Anonymous], 2018, ANT SHORT MAGN CAUS

[3]

[Anonymous], 2019, CHIN API MARK DRUG T

[4]

[Anonymous], 2020, INCR TRANSP MED SUPP

[5]

Chatterjee P, 2020, LANCET, V395, P675, DOI 10.1016/S0140-6736(20)30459-1

[6]

Cogan Deirdre, 2018, Shortages, Stockouts, and Scarcity

[7]

Helander I., 2020, VET OMBEDS MINSKA AN

[8] Transparency throughout the production chain-a way to reduce pollution from the manufacturing of pharmaceuticals? [J].

Larsson, D. G. Joakim ;

Fick, Jerker .

REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2009, 53 (03) :161-163

[9] Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications [J].

Modisakeng, Cynthia ;

Matlala, Moliehi ;

Godman, Brian ;

Meyer, Johanna Catharina .

BMC HEALTH SERVICES RESEARCH, 2020, 20 (01)

[10]

Schondelmeyer S., 2020, Technical Report

← 1 2 →